TR201007652A2 - Synergistic effect. - Google Patents

Synergistic effect.

Info

Publication number
TR201007652A2
TR201007652A2 TR2010/07652A TR201007652A TR201007652A2 TR 201007652 A2 TR201007652 A2 TR 201007652A2 TR 2010/07652 A TR2010/07652 A TR 2010/07652A TR 201007652 A TR201007652 A TR 201007652A TR 201007652 A2 TR201007652 A2 TR 201007652A2
Authority
TR
Turkey
Prior art keywords
synergistic effect
acetylcysteine
sedative
generation
invention includes
Prior art date
Application number
TR2010/07652A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/07652A priority Critical patent/TR201007652A2/en
Priority to PCT/TR2011/000213 priority patent/WO2012039691A2/en
Publication of TR201007652A2 publication Critical patent/TR201007652A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş; bir mukolitik ajan olan N-Asetilsistein ile üçüncü kuşak ve sedatif olmayan Hl reseptör antagonistinin kombine halde kullanılması ve bu kombinasyonu içeren solunum yolu hastalıklarında kullanılabilen ilaç bileşimleri ile ilgilidir.The present invention includes; and N-Acetylcysteine, a mucolytic agent, and a third generation and non-sedative H1 receptor antagonist.

TR2010/07652A 2010-09-20 2010-09-20 Synergistic effect. TR201007652A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/07652A TR201007652A2 (en) 2010-09-20 2010-09-20 Synergistic effect.
PCT/TR2011/000213 WO2012039691A2 (en) 2010-09-20 2011-09-20 Synergic effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/07652A TR201007652A2 (en) 2010-09-20 2010-09-20 Synergistic effect.

Publications (1)

Publication Number Publication Date
TR201007652A2 true TR201007652A2 (en) 2012-04-24

Family

ID=45034153

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/07652A TR201007652A2 (en) 2010-09-20 2010-09-20 Synergistic effect.

Country Status (2)

Country Link
TR (1) TR201007652A2 (en)
WO (1) WO2012039691A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106109422A (en) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 Levo-cetirizine hydrochloride effervescent granule and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184505A (en) 1962-06-18 1965-05-18 Mead Johnson & Co Process for the n-monoacylation of cysteine
DK154078C (en) 1981-02-06 1989-05-22 Ucb Sa METHOD OF ANALOGUE FOR THE PREPARATION OF 2- (2- (4- (DIPHENYL-METHYL) -1-PIPERAZINYL) ETHOXY) -ACETAMIDES OR ACID ADDITION SALTS.
WO1985003707A1 (en) 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
GB8827391D0 (en) 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
EP0950412A3 (en) 1992-09-24 2001-05-16 Sepracor, Inc. Compositions for treating allergic disorders using (-) cetirizine
JP2003532671A (en) * 2000-05-05 2003-11-05 アベンティス・ファーマスーティカルズ・インコーポレイテツド Standardization of packaging for pseudoephedrine hydrochloride and fexofenadine hydrochloride
US7955620B2 (en) * 2003-12-23 2011-06-07 Sun Pharmaceutical Industries Limited Stable oral composition
US20080139654A1 (en) * 2006-12-09 2008-06-12 Eric Mott Soderling Acetaminophen compositions having minimized side effects including reduced hepatotoxicity

Also Published As

Publication number Publication date
WO2012039691A2 (en) 2012-03-29
WO2012039691A3 (en) 2012-05-18

Similar Documents

Publication Publication Date Title
CY1121390T1 (en) PYRROLOVENZODIAZEPINE AND CONCOMES OF THEM
TR201910662T4 (en) Pyrrolobenzodiazepines and their conjugates.
PH12013500065A1 (en) Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
CL2012002979A1 (en) N3-substituted-n1-sulfonyl-5-fluorpyrimidinone derivatives.
BR112013031361A2 (en) cationically and amphiphilically modified galactomannan, and, composition
GB2506783A (en) Enabling a computing device to utilize another computing device
TR201907828T4 (en) AN ANTI-MICROBIAL AGENT WITH A WIDE SPECTRUM
EP3011430A4 (en) Unifying application log messages using runtime instrumentation
UY4223Q (en) BANK
IT1403120B1 (en) WELDING MACHINE WITH ACOUSTIC MESSAGES.
TR201904120T4 (en) Connector part.
CL2009001973S1 (en) Counter.
EP2710024A4 (en) OSW-1 CONJUGATES AND ANALOGUES, AND USES THEREOF
FR2964411B1 (en) DUST OF TURBOREACTOR, IN PARTICULAR A DRAWER OF RECTIFIER, AND TURBOJET RECEIVING SUCH AS AUBES
UY4243Q (en) BANK
TR200903176A1 (en) Multiple blister.
TR201007652A2 (en) Synergistic effect.
IT1399443B1 (en) UNDERGARMENT.
IT1399581B1 (en) DEVICE FOR THE PROTECTION OF PARTS OF THE BODY OF AN INDIVIDUAL, IN PARTICULAR FOR THE BACK PROTECTION.
TR201005220U (en) Innovation in reels used for shipping cables.
TN2010000017A1 (en) مستحضر تجميلي دوائي
TN2010000567A1 (en) المحطة الكهرمائية الشمسية
ES1074160Y (en) BACK TRAY WITH DOUBLE OPENING FOR CAR.
TR200703482A1 (en) An apricot kernel extraction machine
CL2011000970S1 (en) Toothbrush.